4-carbazol-9-yl-11,14-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-1(16),2,4,6,8,10,12,14-octaene-12,13-dicarbonitrile
C28H13N5 — CID 145413747
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-carbazol-9-yl-11,14-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-1(16),2,4,6,8,10,12,14-octaene-12,13-dicarbonitrile
4-carbazol-9-yl-11,14-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-1(16),2,4,6,8,10,12,14-octaene-12,13-dicarbonitrile (PubChem CID 145413747) has the molecular formula C28H13N5 and a molecular weight of 419.45 g/mol. Its IUPAC name is 4-carbazol-9-yl-11,14-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-1(16),2,4,6,8,10,12,14-octaene-12,13-dicarbonitrile.
Molecular Properties
| Compound Name | 4-carbazol-9-yl-11,14-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-1(16),2,4,6,8,10,12,14-octaene-12,13-dicarbonitrile |
|---|---|
| PubChem CID | 145413747 |
| Molecular Formula | C28H13N5 |
| Molecular Weight | 419.45 g/mol |
| Exact Mass | 419.12 |
| IUPAC Name | 4-carbazol-9-yl-11,14-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-1(16),2,4,6,8,10,12,14-octaene-12,13-dicarbonitrile |
| SMILES | N#Cc1nc2c(nc1C#N)-c1ccc(-n3c4ccccc4c4ccccc43)c3cccc-2c13 |
| InChI | InChI=1S/C28H13N5/c29-14-21-22(15-30)32-28-20-12-13-25(18-8-5-9-19(26(18)20)27(28)31-21)33-23-10-3-1-6-16(23)17-7-2-4-11-24(17)33/h1-13H |
| InChIKey | ZIGITOAOZJNTSO-UHFFFAOYSA-N |
| XLogP | 6.12 |
| TPSA | 78.29 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 419.45 |
| LogP ≤ 5 | 6.12 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 145413747 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.